Atlas Trials

Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants

Clinical trial NCT04167137 · TERMINATED

Trial details

NCT number
NCT04167137
Sponsor
Synlogic
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Solid NeoplasmLymphoma
Start date
2019-12-12
Primary completion
2021-12-09
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.